Lack of effect of a gonadotropin-releasing hormone agonist in a patient with prostate cancer and a gonadotroph adenoma

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 864-

  Schuvel, B J ^a   Kirschenbaum, A ^a   Wolfe, D ^a   Post, K D ^a   Levine, A C ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE;

AGED; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; GROWTH STIMULATION; HUMAN; HYPOPHYSIS ADENOMA; INTRAMUSCULAR DRUG ADMINISTRATION; LETTER; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROSTATE CANCER; TESTOSTERONE BLOOD LEVEL; TUMOR GROWTH;

ADENOMA; AGED; HUMANS; LEUPROLIDE; LUTEINIZING HORMONE; MALE; PITUITARY NEOPLASMS; PROSTATIC NEOPLASMS;

EID: 13344270378     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.864     Document Type: Letter

References (0)